CStone Pharmaceuticals Share Price OTC Markets
Stocks
CSPHF
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5945 USD | -14.46% |
|
0.00% | -33.43% |
| 12/06 | CStone Pharmaceuticals Drug Receives Ethics Approval in Australia | MT |
| 11/06 | Cstone Presents Clinical Data for Cs2009 Trispecific Antibody At Asco 2026 | CI |
| Market Cap | 648.96Cr 96Cr 84Cr 77Cr 72Cr 135.69Cr 9.05TCr 136.68Cr 920.21Cr 358.05Cr 4.45TCr 359.71Cr 351.91Cr 15TCr | P/E 2026 * |
-305x | P/E 2027 * | 6.06x |
|---|---|---|---|---|---|
| Enterprise Value | 596.14Cr 88Cr 77Cr 71Cr 66Cr 124.64Cr 8.32TCr 125.56Cr 845.31Cr 328.9Cr 4.09TCr 330.43Cr 323.27Cr 14TCr | EV / Sales 2026 * |
12.4x | EV / Sales 2027 * | 1.68x |
| Free-Float |
77.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | -14.46% | ||
| Current month | -41.14% | ||
| 1 month | -41.14% | ||
| 3 months | -30.97% | ||
| 6 months | -33.43% | ||
| Current year | -33.43% |
| 1 month | 0.59 |  | 0.7 |
| Current year | 0.59 | | 1.01 |
| 1 year | 0.59 | | 1.01 |
| 3 years | 0.11 | | 1.01 |
| 5 years | 0.11 | | 2.5 |
| 10 years | 0 | | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 25/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 18/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 01/08/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 25/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 09/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -14.46% | 0.00% | - | - | 96Cr | |
| +0.42% | -0.40% | +20.16% | -21.46% | 6.23TCr | |
| -0.84% | -4.48% | +57.21% | +196.38% | 5.39TCr | |
| -5.75% | +29.50% | +29.50% | +29.50% | 3.9TCr | |
| -0.48% | +5.73% | -53.34% | -60.16% | 3.79TCr | |
| +1.59% | +0.54% | +57.20% | -32.06% | 2.95TCr | |
| -7.22% | +13.84% | +129.13% | -50.74% | 2.35TCr | |
| +5.54% | +1.65% | +51.42% | +67.44% | 2.07TCr | |
| +0.27% | -1.05% | -4.18% | +148.28% | 1.67TCr | |
| +1.04% | +2.25% | +63.17% | +111.01% | 1.6TCr | |
| Average | -1.98% | +1.40% | +38.92% | +43.13% | 3.33TCr | |
| Weighted average by Cap. | -0.87% | +0.63% | +34.06% | +38.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 48Cr 7.08Cr 6.18Cr 5.72Cr 5.34Cr 10Cr 668.72Cr 10Cr 68Cr 26Cr 328.78Cr 27Cr 26Cr 1.14TCr | 171.33Cr 25Cr 22Cr 20Cr 19Cr 36Cr 2.39TCr 36Cr 242.94Cr 95Cr 1.18TCr 95Cr 93Cr 4.08TCr |
| Net income | -24Cr -3.59Cr -3.14Cr -2.9Cr -2.71Cr -5.08Cr -339.31Cr -5.12Cr -34Cr -13Cr -166.82Cr -13Cr -13Cr -579.54Cr | 69Cr 10Cr 8.87Cr 8.2Cr 7.66Cr 14Cr 959.09Cr 14Cr 97Cr 38Cr 471.55Cr 38Cr 37Cr 1.64TCr |
| Net Debt | -53Cr -7.8Cr -6.81Cr -6.3Cr -5.88Cr -11Cr -736.92Cr -11Cr -75Cr -29Cr -362.32Cr -29Cr -29Cr -1.26TCr | -360.31Cr -53Cr -46Cr -43Cr -40Cr -75Cr -5.03TCr -76Cr -510.92Cr -198.79Cr -2.47TCr -199.72Cr -195.39Cr -8.59TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- CSPHF Stock
Select your edition
All financial news and data tailored to specific country editions
